Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

T B Geijtenbeek1, R Torensma, S J van Vliet

  • 1Department of Tumor Immunology, University Medical Center St. Radboud, Nijmegen, The Netherlands.

Cell
|March 18, 2000
PubMed

Insights

Resting T cells use ICAM-3 to initially contact dendritic cells (DC). A novel DC receptor, DC-SIGN, binds ICAM-3, mediating T cell adhesion and proliferation, crucial for immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Initiating primary immune responses requires contact between dendritic cells (DCs) and resting T cells.
  • Intercellular adhesion molecules (ICAMs) play critical roles in cell-cell interactions within the immune system.

Purpose of the Study:

  • To investigate the role of ICAM-3 on resting T cells in the initial contact with DCs.
  • To identify the specific DC receptor responsible for binding ICAM-3 and mediating T cell adhesion.

Main Methods:

  • Utilized in vitro and in vivo models of DC-T cell interaction.
  • Employed antibody-based inhibition assays to assess the functional role of DC-SIGN.
  • Investigated the binding affinity between ICAM-3 and DC-SIGN.

Main Results:

  • Identified DC-SIGN, a C-type lectin highly expressed on DCs, as a high-affinity receptor for ICAM-3.
  • Demonstrated that DC-SIGN mediates transient adhesion between T cells and DCs.
  • Showed that antibodies blocking DC-SIGN inhibit DC-induced proliferation of resting T cells.

Conclusions:

  • DC-SIGN is a key mediator of the initial contact between T cells and DCs.
  • DC-SIGN binding to ICAM-3 stabilizes the DC-T cell conjugate, facilitating T cell receptor engagement and subsequent T cell activation.
  • These findings highlight DC-SIGN's critical role in initiating adaptive immune responses.